Atlas Trials

Study Evaluating the Efficacy and Safety of 0.05% Ingenol Mebutate (Picato® 500) in the Treatment of Basal Cell Carcinoma

Clinical trial NCT03546166 · COMPLETED

Trial details

NCT number
NCT03546166
Sponsor
Centre Hospitalier Universitaire de Nice
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma
Start date
2018-07-26
Primary completion
2021-03-11
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.